Southchip Semiconductor Technology (Shanghai) (688484.SH) plans to spend no more than 160 million yuan to acquire 100% equity of Shengsheng Micro to expand its product categories in the end-side processor field.
Nanshan technology (688484.SH) announced that the company intends to acquire Zhuhai Shengsheng Microelectronics Co., Ltd. by cash.
Southchip Semiconductor Technology (Shanghai) (688484.SH) announced that the company intends to acquire 100% equity of Zhuhai Shengsheng Microelectronics Co., Ltd. ("Shengsheng Micro" or "target company" or "transaction target") in cash, with a total acquisition price not exceeding 160 million yuan.
It is reported that Shengsheng Micro is a company that provides end-side application processor chips and analog and digital mixed signal chip solutions, mainly engaged in the research and development, production, and sales of RISC-V processors, POWERMCU microcontroller chips, and supporting power management chips. Shengsheng Micro's products mainly serve end-side devices, providing processing chips and solutions for power and energy management in wearable, consumer, industrial, and other fields.
This transaction is beneficial for both parties to integrate their products, technology, markets, customers, and supply chain resources, and to achieve synergies in the embedded field, in line with the company's development vision and long-term strategic planning. Through this transaction, the company will integrate the target company's technical capabilities and R&D team in the field of embedded chip design and development, helping to strengthen the company's technical advantages in embedded chip hardware, IP, algorithms, software, etc. At the same time, this transaction will expand the company's product categories in the end-side processor field and expand the scope of cooperation with customers. In terms of supply chain, through the integration of supply chain resources with the target company, the company will leverage economies of scale to further enhance the cost advantages of raw material procurement for both the company and the target company.
Related Articles

GREAT CHI HLDGS (00021): Wong Man Hei appointed as a new member of the nomination committee

Shandong Sito Bio-technology (300583.SZ): The chemical raw material drug budenide passed the drug GMP compliance inspection.

CH AGRI-PROD EX (00149) releases annual performance, with a net profit attributable to shareholders of 7.8 million Hong Kong dollars, an increase of 5.4% year-on-year.
GREAT CHI HLDGS (00021): Wong Man Hei appointed as a new member of the nomination committee

Shandong Sito Bio-technology (300583.SZ): The chemical raw material drug budenide passed the drug GMP compliance inspection.

CH AGRI-PROD EX (00149) releases annual performance, with a net profit attributable to shareholders of 7.8 million Hong Kong dollars, an increase of 5.4% year-on-year.

RECOMMEND

Trump Signals End to Trade Talks, Vows to Impose Tariffs Unilaterally Ahead of July 9 Deadline
30/06/2025

One License Unlocks HKD 23.4 Billion Surge: Unpacking Hong Kong’s Ambitions as a Global Virtual Asset Hub
30/06/2025

16 Companies Submit IPO Applications in One Day; Hong Kong IPO Fundraising Hits Three-Year High
30/06/2025